Related Experiment Video
Updated: Jan 1, 2026

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
Combination Antibiotic Delivery in PMMA Provides Sustained Broad-Spectrum Antimicrobial Activity and Allows for
Erika L Cyphert1, Chao-Yi Lu1, Dylan W Marques1
1Department of Biomedical Engineering , Case Western Reserve University , 10900 Euclid Avenue , Cleveland , Ohio 44106 , United States.
Abstract:
Antibiotics are commonly added to poly(methyl methacrylate) (PMMA) by surgeons to locally treat infections such as in bone cement for joint replacement surgeries, as well as implantable antimicrobial "beads". However, this strategy is of limited value in high-risk patients where infections can be recurrent or chronic and otherwise hard to treat. Also, when only one drug is incorporated and applied toward polymicrobial infections (multiple bacterial species), there is a high risk that bacteria can develop antibiotic resistance. To combat these limitations, we developed a combination antibiotic PMMA composite system composed of rifampicin-filled β-cyclodextrin (β-CD) microparticles added into PMMA filled with a second drug. Different formulations were evaluated through zone of inhibition, drug activity, antibiotic release, and refilling, as well as mechanical studies. Our combination antibiotic PMMA composite system achieved up to an 8-fold increase in the duration of antimicrobial activity in comparison to clinically used antibiotic-filled PMMA. Inclusion of CD microparticles also allowed for refilling of additional antibiotics after simulated implantation, resulting in additional windows of therapeutic efficacy. Mechanical testing showed that our tested formulations did have a small, but significant decrease in mechanical properties when compared to unmodified controls. While further studies are needed to determine whether the tested formulations are still suitable for load-bearing applications (e.g., bone cement), our composites are certainly amenable for a variety of nonload-bearing applications (e.g., antimicrobial "beads" and temporary spacer in two-stage arthroscopic revisions).
Insights
This study introduces a novel combination antibiotic poly(methyl methacrylate) (PMMA) system using drug-filled microparticles. This advanced antimicrobial composite offers extended efficacy and refilling capabilities for treating challenging bone infections.
Area of Science:
- Biomaterials Science
- Infectious Disease Research
- Drug Delivery Systems
Background:
- Antibiotics in poly(methyl methacrylate) (PMMA) are used for localized infection treatment, but face limitations with chronic/recurrent infections and antibiotic resistance.
- Current single-drug approaches in PMMA are insufficient for polymicrobial infections, increasing the risk of bacterial resistance.
Purpose of the Study:
- To develop and evaluate a combination antibiotic PMMA composite system for enhanced antimicrobial efficacy and duration.
- To investigate the potential for refilling antibiotic-loaded microparticles within the PMMA composite for sustained therapeutic effect.
- To assess the mechanical properties of the developed composite for potential clinical applications.
Main Methods:
- Formulation of a novel PMMA composite incorporating rifampicin-filled β-cyclodextrin (β-CD) microparticles and a second antibiotic.
- Evaluation of antimicrobial activity using zone of inhibition assays and drug release studies.
- Assessment of refilling capabilities and mechanical properties of the composite materials.
Main Results:
- The combination antibiotic PMMA composite demonstrated up to an 8-fold increase in antimicrobial activity duration compared to conventional antibiotic-PMMA.
- The β-cyclodextrin microparticles enabled successful refilling of antibiotics, providing additional therapeutic windows.
- Tested formulations showed a minor but significant decrease in mechanical properties compared to controls.
Conclusions:
- The developed combination antibiotic PMMA composite system offers a promising strategy for prolonged and refillable antimicrobial delivery.
- While mechanical properties require further investigation for load-bearing applications like bone cement, the composite is suitable for non-load-bearing uses such as antimicrobial beads.
- This innovation addresses limitations of current antibiotic-PMMA strategies, offering improved treatment options for challenging bone infections.
Related Concept Videos
Bacterial Signaling
Antibiotic Selection
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Development of Antibiotic Resistance

